New study suggests memory loss in Alzheimer’s is reversible

21 Jun 2016

1

A new research study suggests that the most feared impact of Alzheimer's, namely memory loss could be reversed by a combination of broad-based treatments and personalised therapy.

Researchers of the new study published in the journal Aging on 12 June recruited 10 patients with Alzheimer's disease or cognitive impairment to test a 36-point therapeutic programme that addressed the patient's diet, sleep, exercise, intake of certain medicines and vitamins, and brain stimulation.

All patients who received the therapy showed improvements in memory and cognition and some were even able to complete tasks that had become impossible for them to do because of their declining mental abilities.

"The magnitude of the improvement is unprecedented, providing additional objective evidence that this programmatic approach to cognitive decline is highly effective," study researcher Dale Bredesen, from the Buck Institute for Research on Aging, and colleagues reported in the journal Aging.

The small trial is the first to show that it was possible to reverse memory loss and the improvements could be sustained.

The programme basically revolved around a combination of certain medication, lifestyle and diet and treatment also varied for each of the patients. According to the researchers, the disease was different in every patient which called for personalised approach.

Not only were the patients able to sustain the improvements, but some also returned to work, regained their ability to speak different languages, and showed an increase in brain matter volume after just a few months.

"All of these patients had either well-defined mild cognitive impairment, subjective cognitive impairment, or had been diagnosed with Alzheimer's disease before beginning the program," says one of the team, Dale Bredesen, University of California, Los Angeles. "Follow up testing showed some of the patients going from abnormal to normal."

The treatment - called metabolic enhancement for neurodegeneration, or MEND was based on 36 different factors, which included changes in exercise, and sleeping habits, plus the integration of certain drugs, vitamins, and brain stimulation therapy to their regular routine.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round